ICON Announces Appointment of Chief Operating Officer
18 December 2024 - 11:00PM
Business Wire
ICON plc (NASDAQ: ICLR), a world-leading
healthcare intelligence and clinical research organisation, today
announced the appointment of Barry Balfe as Chief Operating Officer
(COO).
Barry is a long-tenured ICON employee with over 20 years of
service and brings extensive leadership experience and capability
to the role of COO. He has held a number of leadership roles across
both full service and functional solutions at ICON and has very
successfully supported the growth of new and existing customer
partnerships. His strong focus and track record on operational
excellence, quality & delivery will enable the company to
deliver greater value to our customers and further enhance our
strategy to become the healthcare intelligence partner of choice in
the industry.
Barry will continue to report to ICON’s Chief Executive Officer,
Steve Cutler.
“Barry is a vastly experienced leader and has a very strong
reputation across the industry,” said Steve Cutler, ICON’s CEO. “He
has successfully led our largest division over the past number of
years, creating and sustaining strategic partnerships with
customers that have been key to our growth trajectory as a company.
I look forward to working closely with Barry to drive further
growth across the organisation, as we create value for our
customers in delivering their clinical development programs more
efficiently.”
“It is a privilege to serve as ICON’s Chief Operating Officer,”
said Barry Balfe. “I look forward to working with all of our
dedicated colleagues around the world as we continue to drive
superior innovation, execution and delivery for customers and for
patients.”
About ICON plc
ICON plc is a world-leading healthcare intelligence and clinical
research organisation. From molecule to medicine, we advance
clinical research providing outsourced services to pharmaceutical,
biotechnology, medical device and government and public health
organisations. We develop new innovations, drive emerging therapies
forward and improve patient lives. With headquarters in Dublin,
Ireland, ICON employed approximately 42,250 employees in 106
locations in 55 countries as at September 30, 2024. For further
information about ICON, visit: www.iconplc.com.
This press release contains forward-looking statements,
including statements about our financial guidance. These statements
are based on management's current expectations and information
currently available, including current economic and industry
conditions. These statements are not guarantees of future
performance or actual results, and actual results, developments and
business decisions may differ from those stated in this press
release. The forward-looking statements are subject to future
events, risks, uncertainties and other factors that could cause
actual results to differ materially from those projected in the
statements, including, but not limited to, the ability to enter
into new contracts, maintain client relationships, manage the
opening of new offices and offering of new services, the
integration of new business mergers and acquisitions, as well as
other economic and global market conditions and other risks and
uncertainties detailed from time to time in SEC reports filed by
ICON, all of which are difficult to predict and some of which are
beyond our control. For these reasons, you should not place undue
reliance on these forward-looking statements when making investment
decisions. The word "expected" and variations of such words and
similar expressions are intended to identify forward-looking
statements. Forward-looking statements are only as of the date they
are made and we do not undertake any obligation to update publicly
any forward-looking statement, either as a result of new
information, future events or otherwise. More information about the
risks and uncertainties relating to these forward-looking
statements may be found in SEC reports filed by ICON, including its
Form 20-F, F-1, F-4, S-8, F-3 and certain other reports, which are
available on the SEC's website at http://www.sec.gov.
ICON/ICLR-F
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241218803164/en/
Kate Haven Vice President Investor Relations +1 888 381 7923 All
at ICON
ICON (NASDAQ:ICLR)
Historical Stock Chart
From Nov 2024 to Dec 2024
ICON (NASDAQ:ICLR)
Historical Stock Chart
From Dec 2023 to Dec 2024